Active	Status	Sponsor type	Region	Phase	Filter
13 Active 3 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zheng, Xin
NCT04201808: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides	Recruiting	4	100	RoW	Tenofovir Alafenamide 25 MG, Vemlidy	New Discovery LLC, Beijing Ditan Hospital	Hepatitis B, Chronic	09/23	09/23
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
NCT05352516 / 2022-002188-31: A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture	Completed	3	514	RoW	HLX14, Prolia®	Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc.	Postmenopausal	12/23	07/24
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B	Active, not recruiting	3	871	Europe, Canada, Japan, US, RoW	Bepirovirsen, Placebo	GlaxoSmithKline, GlaxoSmithKline Research & Development Limited	Chronic Hepatitis B, Hepatitis B, Chronic	11/25	05/26
NCT04765995: Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects	Not yet recruiting	1	40	RoW	HZBio1 0.96mg / kg, HZBio1 3mg / kg, HZBio1 6mg / kg, HZBio1 9mg / kg, HZBio1 12mg / kg, Placebo	Hangzhou Grand Biologic Pharmaceutical, Inc., Peking Union Medical College Hospital	Healthy Participants	10/21	12/21